Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

“The use of bisphosphonates to treat skeletal complications in solid tumours”
Stella D’Oronzo, Steven L. Wood, Janet E. Brown
Bone (2021) Vol. 147, pp. 115907-115907
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
Konstantinos Venetis, Roberto Piciotti, Elham Sajjadi, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1377-1377
Open Access | Times Cited: 60
Calcium phosphate bone cements as local drug delivery systems for bone cancer treatment
Athanasia Pylostomou, Öznur Demir, Dagnija Loča
Biomaterials Advances (2023) Vol. 148, pp. 213367-213367
Open Access | Times Cited: 23
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
Acidity‐Triggered Transformable Polypeptide Self‐Assembly to Initiate Tumor‐Specific Biomineralization
Yang Liu, Zhongyu Jiang, Shizheng Tong, et al.
Advanced Materials (2022), pp. 2203291-2203291
Closed Access | Times Cited: 36
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
Clara Martori, Lidia Sánchez-Moral, Tony Paul, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 440-440
Open Access | Times Cited: 33
Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis
Nour Arakil, Shahid Akhtar Akhund, Basant Elaasser, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1075-1075
Open Access | Times Cited: 6
A glitch in the matrix: organ-specific matrisomes in metastatic niches
Sarah K. Deasy, Neta Erez
Trends in Cell Biology (2021) Vol. 32, Iss. 2, pp. 110-123
Closed Access | Times Cited: 33
The progressive trend of modeling and drug screening systems of breast cancer bone metastasis
Hanieh Kolahi Azar, Maliheh Gharibshahian, Mohammadreza Rostami, et al.
Journal of Biological Engineering (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs
Jost Klawitter, Michael Easton, Alexander Karpeisky, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 354-354
Open Access
Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study
Y. Zhang, Lixia Xiao, Lan LYu, et al.
PeerJ (2024) Vol. 12, pp. e17098-e17098
Open Access | Times Cited: 2
Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis
Shuting Lin, Yizhong Li, Xiaoqi Sun, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 16
Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment
Lena Batoon, Laurie K. McCauley
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 15
A global bibliometric and visualized analysis of the status and trends of bone metastasis in breast cancer research from 2002 to 2021
Li Li, Nengbin Wan, Ying He, et al.
Journal of bone oncology (2023) Vol. 42, pp. 100500-100500
Open Access | Times Cited: 5
Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database
C. Amigues, Audrey Fresse, C. Roux, et al.
Joint Bone Spine (2023) Vol. 90, Iss. 6, pp. 105599-105599
Open Access | Times Cited: 4
Multidimensional analysis to elucidate the possible mechanism of bone metastasis in breast cancer
Kang Yao, Xiaojun Zhu, Tingxiao Zhao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Insight into prostate cancer osteolytic metastasis by RelB coordination of IL‐8 and S100A4
Wenbo Sun, Kai Xu, Xiao Li, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 1
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast Cancer
Kai Jannusch, Ann‐Kathrin Bittner, Nils Martin Bruckmann, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1651-1651
Open Access | Times Cited: 3
Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature
María Lorena Brance, Nicolás M. Cóccaro, Pablo Roitman, et al.
Archives of Osteoporosis (2022) Vol. 17, Iss. 1
Closed Access | Times Cited: 4
Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A2
Maria Mangini, Rosa D’Angelo, Caterina Vinciguerra, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 4
A multifaceted role of bisphosphonates from palliative care to anti-cancer therapy in solid tumors
Sindhusha Veeraballi, Sai Samyuktha Bandaru, Chrystina Kiwan, et al.
Journal of Oncology Pharmacy Practice (2024)
Closed Access
Silver and Silver/Sodium Bisphosphonate Salts: Rare Examples of Molecular Solid Solutions and Their Biological Activity as Dual-Action Compounds
Karolina Gutmańska, Michał Bartmański, Anna Ronowska, et al.
Crystal Growth & Design (2024)
Closed Access
Prevalence and factors associated with the occurrence of pathological fractures and their impact on the overall survival of patients with bone metastases under palliative care
Juliana Miranda Dutra de Resende, Livia Costa de Olivera, Suzana Sales de Aguiar, et al.
BMJ Supportive & Palliative Care (2023) Vol. 14, Iss. e2, pp. e2028-e2035
Closed Access | Times Cited: 1
Tumour-on-a-Chip: Perfusion Systems to Model the Extracellular Breast Tumour Microenvironment—From Tumour Progression to Metastasis Formation
Annalisa Tirella
(2022), pp. 681-694
Closed Access | Times Cited: 2
Expected survival of cancer and myeloma patients undergoing bisphosphonates or denosumab. Potential impact on diagnosis and management of Osteonecrosis of Jaws (ONJ)
Vittorio Fusco, Marco Cabras, Alessio Gambino, et al.
(2021)
Open Access | Times Cited: 2
Anti‑metastatic activity of aromatic aminomethylidenebisphosphonates in a mouse model of 4T1 cell‑derived breast cancer
Anna Nasulewicz‐Goldeman, Waldemar Goldeman, Diana Papiernik, et al.
Oncology Reports (2023) Vol. 50, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top